PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe
Go back to PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe| (NASDAQ: PDSB) | Delayed: 0.75 +0.02 (2.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.73 | 52 Week High | $ | |||
| Open | $0.75 | 52 Week Low | $ | |||
| Day High | $0.76 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $ | |||
| Volume | 408,248 | |||||

